Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Stocktreeon Feb 23, 2024 3:48pm
108 Views
Post# 35896387

RE:RE:"the best way to enhance shareholder value is" simply

RE:RE:"the best way to enhance shareholder value is" simply- FDA did not pre-approve PMX, so nothing there.
- Baxter just bought 10 yrs of potential distribution for nothing. That absolutely does not confirm anything great about the results, unless you have the dumbest management of all time.
- What did Toray and Birchill say about this new development? Right, nothing.
- This team of investigators (with Kellum on board, which is a conflict of interest) said they are quite confident that a healthy debate of their approach will be had once the trial ends
- You can't quote the analyst to support your claims of grandeur if you say at the same time they are not optimistic enough, dude.
- Your gang of pumpers have been wrong about the value of this stock for years and years.
- I have a stake in PMX's success, but I am not banking on a Quasar level of growth. You guys, on the other hand, always project miraculous numbers, and when they don't occur, just say, mmeh, we still got to 60 something cents for a while, just on pumping.
- And now that the bubble is bursting, it's all the fault of the naysayers.

When did the FDA, Toray, Birchill, investigators, Kellum or the analyst say EDT's stock will most certainly be worth multiple to tens of dollars? Never. That's you pumpers.

But thanks for participating.


<< Previous
Bullboard Posts
Next >>